paralysis therapy - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Tata Power targets 2.8 GW data-centre opportunity pipeline as Rs 15,000cr Mumbai grid plan advances

Fluence wins Vattenfall’s 1 GWh German battery storage contract as shares face pressure

Essar Oil & Gas adds five CBM blocks with 6.6 Tcf of gas in place

Essar Oil & Gas secures five coal-bed methane blocks with 6.6 Tcf gas-in-place potential

Editorial infographic showing an oil refinery at sunset with market-style chart lines and key ExxonMobil Q3 2026 indicators, including a $4.5 billion refining-margin uplift, a $1.3 billion upstream hit from lower liquids prices, a $2.5 billion timing effect, and an October 30, 2026 results date.

ExxonMobil signals $4.5bn refining earnings boost as oil-price pressure hits upstream

VIVATRONIX and SpineX secure CDSCO approval for xStep device Can India’s new neuromodulation era transform paralysis care

Read More

Healthcare Industry News

VIVATRONIX and SpineX secure CDSCO approval for xStep device: Can India’s new neuromodulation era transform paralysis care?

India approves VIVATRONIX–SpineX xStep device for paralysis care—marking a major leap for noninvasive neuromodulation and India’s medtech future.

byPallavi Madhiraju

October 11, 2025

web analytics